Compounds > w 7
Page last updated: 2024-08-16

w 7 and fluorouracil

w 7 has been researched along with fluorouracil in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lönn, S; Lönn, U; Nylen, U; Winblad, G1
Iwano, I; Kikuchi, Y; Kita, T; Kizawa, I; Kuki, E; Miyauchi, M; Oomori, K1
Kato, K; Kikuchi, Y; Kizawa, I; Oomori, K1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1

Other Studies

4 other study(ies) available for w 7 and fluorouracil

ArticleYear
Increased levels of 5-fluorouracil-induced DNA lesions in Bloom's syndrome.
    International journal of cancer, 1990, Mar-15, Volume: 45, Issue:3

    Topics: Aphidicolin; Bloom Syndrome; Cell Cycle; Cell Line; Diterpenes; DNA; DNA Damage; DNA Glycosylases; DNA Repair; Fluorouracil; Humans; N-Glycosyl Hydrolases; Sulfonamides; Uracil-DNA Glycosidase

1990
Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas.
    Gynecologic oncology, 1989, Volume: 35, Issue:2

    Topics: Animals; Calmodulin; Carcinoma; Drug Combinations; Drug Synergism; Female; Fluorouracil; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Sulfonamides; Tegafur; Time Factors; Uracil

1989
Adjuvant effects of calmodulin antagonists to 5-fluorouracil on tumor cell proliferation and the mechanisms.
    Gynecologic oncology, 1987, Volume: 26, Issue:2

    Topics: Adenocarcinoma; Calmodulin; Cell Division; Cell Line; Female; Fluorouracil; Humans; Ovarian Neoplasms; Sulfonamides

1987
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009